BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15052337)

  • 1. The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components.
    Sundaram M; Cook HW; Byers DM
    Biochem Cell Biol; 2004 Feb; 82(1):191-200. PubMed ID: 15052337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of myristoylated alanine-rich protein kinase C substrate to phosphoinositides attenuates the phosphorylation by protein kinase C.
    Seki K; Sheu FS; Huang KP
    Arch Biochem Biophys; 1996 Feb; 326(2):193-201. PubMed ID: 8611023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the binding of myristoylated alanine-rich C kinase substrate (MARCKS) related protein to lipid bilayer membranes by calmodulin.
    Vergères G; Ramsden JJ
    Arch Biochem Biophys; 2000 Jun; 378(1):45-50. PubMed ID: 10871043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MARCKS regulates lamellipodia formation induced by IGF-I via association with PIP2 and beta-actin at membrane microdomains.
    Yamaguchi H; Shiraishi M; Fukami K; Tanabe A; Ikeda-Matsuo Y; Naito Y; Sasaki Y
    J Cell Physiol; 2009 Sep; 220(3):748-55. PubMed ID: 19475567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MARCKS is a major PKC-dependent regulator of calmodulin targeting in smooth muscle.
    Gallant C; You JY; Sasaki Y; Grabarek Z; Morgan KG
    J Cell Sci; 2005 Aug; 118(Pt 16):3595-605. PubMed ID: 16046479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein.
    Corradin S; Ransijn A; Corradin G; Bouvier J; Delgado MB; Fernandez-Carneado J; Mottram JC; Vergères G; Mauël J
    Biochem J; 2002 Nov; 367(Pt 3):761-9. PubMed ID: 12137567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) modulates the properties of MARCKS proteins.
    Schmitz AA; Pleschke JM; Kleczkowska HE; Althaus FR; Vergères G
    Biochemistry; 1998 Jun; 37(26):9520-7. PubMed ID: 9649335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of the protein kinase C substrates MARCKS and MRP in the postnatal developing rat brain.
    McNamara RK; Lenox RH
    J Comp Neurol; 1998 Aug; 397(3):337-56. PubMed ID: 9674561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein (MRP) to vesicular phospholipid membranes.
    Vergères G; Ramsden JJ
    Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):5-11. PubMed ID: 9461483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP) in the prefrontal cortex and hippocampus of suicide victims.
    McNamara RK; Hyde TM; Kleinman JE; Lenox RH
    J Clin Psychiatry; 1999; 60 Suppl 2():21-6; discussion 40-1, 113-6. PubMed ID: 10073384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin basic protein as a "PI(4,5)P2-modulin": a new biological function for a major central nervous system protein.
    Musse AA; Gao W; Homchaudhuri L; Boggs JM; Harauz G
    Biochemistry; 2008 Sep; 47(39):10372-82. PubMed ID: 18767817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium binding and conformational properties of calmodulin complexed with peptides derived from myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP).
    Porumb T; Crivici A; Blackshear PJ; Ikura M
    Eur Biophys J; 1997; 25(4):239-47. PubMed ID: 9112755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MARCKS-related protein binds to actin without significantly affecting actin polymerization or network structure. Myristoylated alanine-rich C kinase substrate.
    Wohnsland F; Steinmetz MO; Aebi U; Vergères G
    J Struct Biol; 2000 Sep; 131(3):217-24. PubMed ID: 11052894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the effector domain of MARCKS and MARCKS-related protein with lipid membranes revealed by electric potential measurements.
    Bähr G; Diederich A; Vergères G; Winterhalter M
    Biochemistry; 1998 Nov; 37(46):16252-61. PubMed ID: 9819217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of myristoylated alanine-rich C kinase substrate (MARCKS)-related protein with a novel solid-supported lipid membrane system (TRANSIL).
    Schmitz AA; Schleiff E; Röhring C; Loidl-Stahlhofen A; Vergères G
    Anal Biochem; 1999 Mar; 268(2):343-53. PubMed ID: 10075825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between myristoylated alanin-rich C kinase substrate (MARCKS) translocation and cortical granule exocytosis in rat eggs.
    Eliyahu E; Shtraizent N; Tsaadon A; Shalgi R
    Reproduction; 2006 Feb; 131(2):221-31. PubMed ID: 16452716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myristoylated alanine-rich C kinase substrate, but not Ca2+/calmodulin-dependent protein kinase II, is the mediator in cortical granules exocytosis.
    Tsaadon L; Kaplan-Kraicer R; Shalgi R
    Reproduction; 2008 May; 135(5):613-24. PubMed ID: 18296509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains.
    Glaser M; Wanaski S; Buser CA; Boguslavsky V; Rashidzada W; Morris A; Rebecchi M; Scarlata SF; Runnels LW; Prestwich GD; Chen J; Aderem A; Ahn J; McLaughlin S
    J Biol Chem; 1996 Oct; 271(42):26187-93. PubMed ID: 8824266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a selective protein kinase C substrate derived from the MARCKS phosphorylation site domain for use in brain tissue homogenates.
    Mundy WR; Sutton LD
    Anal Biochem; 2000 Feb; 278(2):185-91. PubMed ID: 10660461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.